$41.52B
Revenue
$7.46B
Net Income
77.68%
Gross Margin
20.06%
Op. Margin
$20.88B
Free Cash Flow
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $11.20B | $10.26B | $10.24B | $9.83B | $9.99B | $9.44B | $9.32B |
| Revenue Growth % (YoY) | 12.1% | 8.6% | 9.8% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $2.51B | $2.25B | $2.24B | $2.27B | $2.22B | $2.10B | $2.16B |
| Gross Profit | $8.69B | $8.00B | $7.99B | $7.56B | $7.78B | $7.34B | $7.17B |
| Gross Margin % | 77.6% | 78.0% | 78.1% | 77.0% | 77.8% | 77.7% | 76.8% |
| Operating Expenses | $6.82B | $5.82B | $5.66B | $5.62B | $5.96B | $5.45B | $5.38B |
| Research & Development | $1.62B | $1.43B | $1.48B | $1.46B | $1.42B | $1.36B | $1.35B |
| Operating Income | $1.87B | $2.19B | $2.33B | $1.94B | $1.82B | $1.89B | $1.78B |
| Operating Margin % | 16.7% | 21.3% | 22.8% | 19.8% | 18.2% | 20.0% | 19.1% |
| Interest Expense | $181.00M | $28.00M | $87.00M | $28.00M | $126.00M | $28.00M | $90.00M |
| Other Income/Expense | $-52.00M | $61.00M | $68.00M | $95.00M | $72.00M | $70.00M | $91.00M |
| Income Before Tax | $2.63B | $2.51B | $2.41B | $1.97B | $1.99B | $1.75B | $1.84B |
| Income Tax Expense | $685.00M | $426.00M | $519.00M | $433.00M | $280.00M | $219.00M | $408.00M |
| Net Income | $1.94B | $2.09B | $1.89B | $1.54B | $1.71B | $1.53B | $1.43B |
| Net Margin % | 17.3% | 20.3% | 18.4% | 15.7% | 17.1% | 16.2% | 15.3% |
| Basic EPS | 2.08 | 2.20 | 1.97 | 1.61 | 1.78 | 1.60 | 1.48 |
| Diluted EPS | 2.07 | 2.19 | 1.96 | 1.59 | 1.76 | 1.58 | 1.47 |
| Basic Shares Outstanding | - | 948.0M | 956.0M | 960.0M | -1.0M | 956.0M | 964.0M |
| Diluted Shares Outstanding | - | 952.0M | 962.0M | 970.0M | -1.0M | 965.0M | 973.0M |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.33B | $8.98B | $10.37B | $10.93B | $8.85B | $8.00B | $7.68B |
| Accounts Receivable | $14.34B | $5.47B | $5.60B | $4.35B | $11.95B | $4.74B | $5.39B |
| Other Current Assets | $2.24B | $2.43B | $2.50B | $2.18B | $1.78B | $2.09B | $1.98B |
| Total Current Assets | $28.22B | $21.06B | $25.33B | $25.87B | $29.73B | $21.43B | $21.86B |
| Goodwill | $57.94B | $52.46B | $51.44B | $51.28B | $51.28B | $49.09B | $48.94B |
| Intangible Assets | $6.82B | $3.49B | $3.67B | $4.03B | $4.43B | $4.12B | $4.42B |
| Other Non-current Assets | $3.63B | $4.33B | $4.60B | $4.89B | $4.77B | $4.21B | $4.03B |
| Total Assets | $112.31B | $95.14B | $97.57B | $98.61B | $102.93B | $91.39B | $92.18B |
| Deferred Revenue | $24.32B | $15.00B | $16.55B | $17.80B | $20.74B | $13.47B | $15.22B |
| Total Current Liabilities | $37.12B | $21.41B | $22.53B | $24.20B | $27.98B | $19.38B | $21.00B |
| Long-term Debt | $14.44B | $8.44B | $8.44B | $8.44B | $8.43B | $8.43B | $8.43B |
| Other Non-current Liabilities | $3.42B | $3.14B | $3.06B | $2.97B | $2.96B | $2.64B | $2.71B |
| Total Liabilities | $53.16B | $35.12B | $36.24B | $37.94B | $41.76B | $32.87B | $34.55B |
| Common Stock | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| Retained Earnings | $22.22B | $20.67B | $18.99B | $17.50B | $16.37B | $15.05B | $13.91B |
| Total Stockholders Equity | $59.14B | $60.02B | $61.33B | $60.67B | $61.17B | $58.52B | $57.63B |
| Total Liabilities & Equity | $112.31B | $95.14B | $97.57B | $98.61B | $102.93B | $91.39B | $92.18B |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $1.94B | $2.09B | $3.43B | $1.54B | $1.71B | $1.53B | $1.43B |
| Depreciation & Amortization | $-1.31B | $851.00M | $817.00M | $843.00M | $-1.60B | $2.60B | $1.79B |
| Stock-based Compensation | $1.08B | $819.00M | $1.61B | $814.00M | $803.00M | $2.38B | $810.00M |
| Change in Receivables | $8.63B | $-123.00M | $1.24B | $-7.59B | $7.17B | $-655.00M | $-6.03B |
| Operating Cash Flow | $5.46B | $2.32B | $7.22B | $6.48B | $3.97B | $9.12B | $892.00M |
| Capital Expenditure | $141.00M | $139.00M | $135.00M | $179.00M | $154.00M | $204.00M | $137.00M |
| Acquisitions | $8.24B | $978.00M | $54.00M | - | $2.22B | $179.00M | $338.00M |
| Sales of Investments | $78.00M | $452.00M | $1.43B | $436.00M | $939.00M | $905.00M | $898.00M |
| Investing Cash Flow | $-8.71B | $519.00M | $-402.00M | $-1.57B | $-2.94B | $-217.00M | $-10.00M |
| Stock Repurchased | $3.94B | $3.80B | $4.86B | $2.63B | $76.00M | $7.75B | $4.33B |
| Dividends Paid | $391.00M | $395.00M | $801.00M | $402.00M | $383.00M | $382.00M | $384.00M |
| Financing Cash Flow | $1.59B | $-4.24B | $-5.42B | $-2.92B | $-73.00M | $-9.36B | $-5.80B |
| Net Change in Cash | $-1.65B | $-1.39B | $1.52B | $2.08B | $851.00M | $-475.00M | $-2.28B |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $10.26B | - | $30.32B | - |
| Cost of Revenue | $2.25B | - | $6.76B | - |
| Gross Profit | $8.00B | - | $23.56B | - |
| Operating Expenses | $5.82B | - | $17.10B | - |
| Research & Development | $1.43B | - | $4.37B | - |
| Operating Income | $2.19B | - | $6.46B | - |
| Interest Expense | $28.00M | - | $143.00M | - |
| Other Income/Expense | $61.00M | - | $224.00M | - |
| Income Before Tax | $2.51B | - | $6.89B | - |
| Income Tax Expense | $426.00M | - | $1.38B | - |
| Net Income | $2.09B | $1.43B | $5.51B | - |
| Basic EPS | 2.20 | - | 5.77 | - |
| Diluted EPS | 2.19 | - | 5.73 | - |
| Basic Shares Outstanding | $948.00M | - | $955.00M | - |
| Diluted Shares Outstanding | $952.00M | - | $962.00M | - |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $8.98B | $8.85B |
| Accounts Receivable | $5.47B | $11.95B |
| Other Current Assets | $2.43B | $1.78B |
| Total Current Assets | $21.06B | $29.73B |
| Goodwill | $52.46B | $51.28B |
| Intangible Assets | $3.49B | $4.43B |
| Other Non-current Assets | $4.33B | $4.77B |
| Total Assets | $95.14B | $102.93B |
| Deferred Revenue | $15.00B | $20.74B |
| Total Current Liabilities | $21.41B | $27.98B |
| Long-term Debt | $8.44B | $8.43B |
| Other Non-current Liabilities | $3.14B | $2.96B |
| Total Liabilities | $35.12B | $41.76B |
| Common Stock | $1.00M | $1.00M |
| Retained Earnings | $20.67B | $16.37B |
| Total Stockholders Equity | $60.02B | $61.17B |
| Total Liabilities & Equity | $95.14B | $102.93B |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $2.09B | $1.43B | $5.51B | - |
| Depreciation & Amortization | $851.00M | - | $2.51B | - |
| Stock-based Compensation | $819.00M | - | $2.43B | - |
| Change in Receivables | $-123.00M | - | $-6.47B | - |
| Operating Cash Flow | $2.32B | - | $9.53B | - |
| Capital Expenditure | $139.00M | - | $453.00M | - |
| Acquisitions | $978.00M | - | $1.03B | - |
| Sales of Investments | $452.00M | - | $2.32B | - |
| Investing Cash Flow | $519.00M | - | $117.00M | - |
| Stock Repurchased | $3.80B | - | $8.66B | - |
| Dividends Paid | $395.00M | - | $1.20B | - |
| Financing Cash Flow | $-4.24B | - | $-9.67B | - |
| Net Change in Cash | $-1.39B | - | $130.00M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.